Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis.
Publication/Presentation Date
8-1-2019
Volume
5
Issue
8
First Page
663
Last Page
665
ISSN
2352-5126
Published In/Presented At
Shalabi, D., Sethi, M., Okon, L., Debes, G. F., Lee, J. B., & Nikbakht, N. (2019). Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis. JAAD case reports, 5(8), 663–665. https://doi.org/10.1016/j.jdcr.2019.06.002
Disciplines
Medicine and Health Sciences
PubMedID
31388533
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article
COinS